Charles A. Reinhart
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles A. Reinhart
Charles A. Reinhart was last confirmed as CFO at Pacira BioSciences, Inc. (PCRX) in a filing dated April 22, 2024. The proxy statement of Pacira BioSciences, Inc. reports total compensation of $1,284,544 for Charles A. Reinhart in fiscal 2024, including a base salary of $374,173. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-04-22
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Pacira BioSciences, Inc. (PCRX) | Former Chief Financial Officer | $374,173 | $1,284,544 |
| 2023 | Pacira BioSciences, Inc. (PCRX) | Former Chief Financial Officer | $486,671 | $1,427,428 |
| 2022 | Pacira BioSciences, Inc. (PCRX) | Former Chief Financial Officer | $475,000 | $1,751,228 |
| 2019 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | $433,512 | $1,389,744 |
| 2018 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | $420,827 | $1,407,673 |
| 2017 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | $408,654 | $1,318,935 |
Recent activity
No call appearances or filed executive changes recorded yet.